Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS‐CoV‐2 Vaccination: A Systematic Review
Journal of Skin Cancer · 2026-01 · 2026 (1)
DOI: 10.1155/jskc/4893577 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Skin Cancer, online erschienen am 28.05.2026. Verfasst von Martina Mussi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy, unibo.it. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Bologna.
Abstract (Originalsprache)
Background
Cutaneous lymphomas (CLs) are rare neoplastic skin disorders, primarily of T‐cell origin. Since the widespread rollout of SARS‐CoV‐2 vaccines, several cases of CLs and non‐neoplastic lymphoproliferative disorders (nn‐LPDs) temporally associated with vaccination have been reported, raising concerns about a potential immunologic link.
Objective
To systematically review the literature on cases of CLs and related nn‐LPDs occurring after COVID‐19 vaccination, focusing on clinical features, subtype distribution, latency to onset, and proposed pathophysiological mechanisms.
Methods
A systematic review was conducted according to PRISMA guidelines. Case reports and series describing new‐onset or relapsed CLs or nn‐LPDs temporally following SARS‐CoV‐2 vaccination were included. Demographic, clinical, histological, therapeutic and temporal data were extracted and analysed.
Results
Fifteen manuscripts encompassing 35 cases met the inclusion criteria. Eighteen (51.4%) were histologically confirmed CLs, most commonly lymphomatoid papulosis ( n = 9), followed by Sézary syndrome ( n = 3) and mycosis fungoides ( n = 2). The remaining 17 cases (48.6%) were classified as nn‐LPDs, including cutaneous lymphoid hyperplasia, lymphomatoid reactions and CD4+ small/medium T‐cell lymphoproliferative disorders. CD30 positivity was noted in 76.2% of the cases with available immunophenotyping. Most patients (80%) received the BNT162b2 (Pfizer–BioNTech) vaccine. In the 17 new‐onset CLs, time to onset ranged from 3 to 42 days, with most cases clustering within 14 days.
Conclusions
Most of the cases were low‐grade T‐cell CLs and nn‐LPDs. Although a causal relationship cannot be established, the short latency observed in many new‐onset cases raises the possibility that some patients may have harboured an undiagnosed disease, with vaccination acting as a trigger for clinical manifestation or for raised awareness. These findings support indeed the need for continued pharmacovigilance among clinicians, especially in patients with prior or latent lymphoproliferative conditions. Nevertheless, these extremely rare and indolent events should not alter the overall favourable risk–benefit profile of COVID‐19 vaccination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy, unibo.it.
- Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy, ulssvicenza.it.
- Department of Medical Sciences, Section of Hematology and Rheumatology, University of Ferrara, Ferrara, Italy, unife.it.
ORCID-Profile: Martina Mussi, Corrado Zengarini, Alberto Corrà, Tullio Brunetti, Alessio Natale, Michelangelo La Placa, Bianca Maria Piraccini, Alba Guglielmo, Alessandro Pileri
Förderung
- Università di Bologna
Zitieren
APA
Mussi, M., Zengarini, C., Corrà, A., Brunetti, T., Natale, A., La Placa, M., Piraccini, B. M., Guglielmo, A., & Pileri, A. (2026). Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS‐CoV‐2 Vaccination: A Systematic Review. Journal of Skin Cancer, 2026(1). https://doi.org/10.1155/jskc/4893577
Vancouver
Mussi M, Zengarini C, Corrà A, Brunetti T, Natale A, La Placa M, et al. Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS‐CoV‐2 Vaccination: A Systematic Review. Journal of Skin Cancer. 2026;2026(1). doi:10.1155/jskc/4893577
BibTeX
@article{Mussi2026,
author = {Mussi, Martina and Zengarini, Corrado and Corrà, Alberto and Brunetti, Tullio and Natale, Alessio and La Placa, Michelangelo and Piraccini, Bianca Maria and Guglielmo, Alba and Pileri, Alessandro},
title = {Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS‐CoV‐2 Vaccination: A Systematic Review},
journal = {Journal of Skin Cancer},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jskc/4893577}
}
EUVIMED